首页|结核分枝杆菌复合群及耐药基因突变检测试剂盒诊断结核分枝杆菌耐药效果研究

结核分枝杆菌复合群及耐药基因突变检测试剂盒诊断结核分枝杆菌耐药效果研究

扫码查看
目的 评价结核分枝杆菌复合群及耐药基因突变检测试剂盒(GenoType MTBDRplus VER2.0,简称MTB-DRplus 2.0)检测利福平和异烟肼耐药的灵敏度和特异度等效能指标,为提高结核分枝杆菌耐药性检测水平提供依据.方法 收集2022年1-12月云南省32个县(市、区)级结核病定点治疗医院分离培养的阳性菌株,经MTBDRplus 2.0检出结核分枝杆菌880株,进行最低抑菌浓度(minimum inhibitory concentration,MIC)法药敏试验检测.结果 以MIC法为金标准,MTBDRplus 2.0检测异烟肼耐药的灵敏度为67.69%,特异度为98.40%,阳性预测值为77.19%,阴性预测值为97.45%,MTBDRplus 2.0和MIC法检测异烟肼耐药结果一致性中等,Kappa为0.701(P<0.001);检测利福平耐药的灵敏度为87.80%,特异度为99.40%,阳性预测值为87.80%,阴性预测值为99.40%,MTBDRplus 2.0和MIC法检测利福平耐药结果一致性较好,Kappa为0.872(P<0.001).MTBDRplus 2.0结果显示对异烟肼耐药而MIC法结果为对异烟肼敏感的13株菌中,发生inhA(C15T)突变有11株(占84.62%),MTBDRplus 2.0结果显示对利福平耐药而MIC法结果为对利福平敏感5株菌中,发生rpoB其他突变有4株(80.00%).结论 MTBDRplus 2.0检测利福平耐药的灵敏度和特异度均较高,但检测异烟肼耐药的灵敏度略低,检测异烟肼耐药的灵敏度低可能是由于试剂盒检测异烟肼耐药的靶点覆盖不足.inhA基因突变与异烟肼耐药的相关性较差,rpoB基因其他突变与利福平耐药的相关性较差.
Evaluation of MTBDRplus 2.0 in the diagnosis of drug resistance of Mycobacterium tuberculosis
Objective To evaluate the sensitivity and specificity of the GenoType MTBDRplus V2.0(Mycobacterium tuberculosis and resistance gene detection assay kit using PCR-linear probe hybridization with enzyme chromogenic method,referred to as MTBDRplus 2.0)kit for detection of rifampin and isoniazid resistance,providing the basis for improving the detection of drug-resistant Mycobacterium tuberculosis.Methods From January to December 2022,positive strains of Mycobacterium tuberculosis isolated and cultured from designated tuberculosis treatment hospitals in 32 counties(cities,districts)of Yunnan Province were collected.Resistance in 880 strains of Mycobacterium tuberculosis was detected by MTBDRplus 2.0,and the minimum inhibitory concentration(MIC)method was used for the drug sensitivity test.Results Using the MIC method as the gold standard,the sensitivity,specificity,positive predictive value,and negative predictive value of MTBDRplus 2.0 in detecting isoniazid resistance were 67.69%,98.40%,77.19%,and 97.45%,respectively.The consistency of the linear probe method and MIC method in detecting isoniazid resistance was moderate,with a Kappa value of 0.701(P<0.001);the sensitivity,specificity,positive predictive value,and negative predictive values of MTBDRplus 2.0 in detecting rifampicin resistance were 87.80%,99.40%,87.80%,and 99.40%,respectively.The consistency of rifampicin resistance detection between MTBDRplus 2.0 and MIC method was relatively good,with a Kappa value of 0.872(P<0.001).Among the 13 strains showing resistance to isoniazid with MTBDRplus 2.0,but sensitivity according to the MIC method,11 strains(84.62%)had mutations in the inhA gene(C15T).Out of the 5 strains showing resistance to rifampicin with MTBDRplus 2.0,but sensitivity according to the MIC method,4 strains(80.00%)had other mutations in the rpoB gene.Conclusions MTBDRplus 2.0 shows high sensitivity and specificity in detecting rifampicin resistance,but slightly low sensitivity in detecting isoniazid resistance.The low sensitivity in detecting isoniazid resistance may be due to insufficient target coverage of the detection kit.inhA gene mutations are poorly correlated with isoniazid resistance,and other mutations in the rpoB gene are poorly correlated with rifampicin resistance.

Mycobacterium tuberculosisMTBDRplus 2.0minimum inhibitory concentrationdrug resistance

茹浩浩、杨星、陈连勇、陈涛、闫双群、许琳

展开 >

云南省疾病预防控制中心,云南昆明 650022

结核分枝杆菌 结核分枝杆菌复合群及耐药基因突变检测试剂盒 最低抑菌浓度法 耐药

国家自然科学基金

82060613

2024

中国热带医学
中华预防医学会,海南疾病预防控制中心

中国热带医学

CSTPCD北大核心
影响因子:0.722
ISSN:1009-9727
年,卷(期):2024.24(3)
  • 20